ArticleBiomolecules & biomedicine2026
A remarkable year for NSCLC: Seven new FDA approvals in 2025 across molecular targets.
Krešimir Tomić et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleBiomolecules & biomedicine2026
Krešimir Tomić et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.